Skip to main content
OpenTrials
Completed

NCT Number: NCT06336577

Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-France

The purpose of this study is to describe infectious and non-infectious lower respiratory tract diseases in children with Down syndrome followed in pediatric pulmonology consultations in Ile de France.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Down syndrome is the most common chromosomal abnormality, affecting 600 to 800 births per year. It results in a clinical picture that combines developmental delay, mental deficiency, facial dysmorphism and visceral malformations.

Optimal medical care of Down syndrome patients requires a good knowledge of the different systems affected by the disease, particularly respiratory damage.

Numerous articles have been published describing upper respiratory problems in children with Down syndrome. On the other hand, lower respiratory problems causing significant morbidity and mortality remain underestimated and poorly understood in this population.

The objective of this study is to describe lower respiratory problems in patients with T21, in order to improve their management.

This study will also make it possible to describe more precisely the impact that these attacks have on Down syndrome patients.

This study also describe the associated extra-respiratory disorders to improve overall care Finally, the respiratory care of these patients will be described, with the aim of standardizing practices.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Child from 0 to 17 years old
  • Carrier of Down syndrome confirmed by karyotype
  • Having had follow-up in a pediatric pulmonology consultation for an infectious or non-infectious lower respiratory tract
  • Not exclusively presenting upper respiratory otorhinolaryngological damage

Exclusion criteria

  • Patient under guardianship or curators
  • Adult or holders of parental authority informed of the study and having objected to it

Treatment and study plan

lower respiratory tract disease

Other

lower respiratory tract disease

Primary outcomes

  1. distribution of lower respiratory tract diseases

    Time frame: at day 0

    number

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Sud Francilien

Other

Registry information

Acronym: ARBT21

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Mar 28, 2024
Registry last updated
Aug 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.